Investor insights
Sectors invested in
Funding rounds participated in
$75M sweet spot round size
Most of their 165 investments are in rounds between $31M and $112M
Basic info
Industry
Sectors
Date founded
1985
Investments made
PayJoy raised $150M on September 5, 2023
Investors: Union Square Ventures, Greylock Partners, Warburg Pincus LLC and The Invus Group
Taysha Gene Therapies raised $150M on August 14, 2023
Investors: RTW Investments, LP, Octagon Capital Advisors, GordonMD Global Investments LP, PBM Capital Group, RA Capital Management, L.P., TCG X, B Capital Group and The Invus Group
GenSight Biologics raised $6.6M on August 3, 2023
Investors: UPMC Enterprises, Sofinnova Partners and The Invus Group
Sensorion raised $38M on August 3, 2023
Investors: Redmile Group, Sofinnova Partners and The Invus Group
Septerna raised $150M on July 11, 2023
Investors: Goldman Sachs Asset Management, Third Rock Ventures, Woodline Partners LP, RA Capital Management, L.P., Soleus Capital Management, L.P., Samsara BioCapital, Logos Global Management, LP, Vertex Ventures HC and The Invus Group
Convergent Therapeutics, Inc. raised $90M on May 3, 2023
Investors: RA Capital Management, L.P., OrbiMed Advisors and The Invus Group
Orbital Therapeutics raised $270M on April 26, 2023
Investors: Heritage Medical Systems, Newpath Partners, ARCH Venture Partners, Redmile Group, Casdin Capital, LLC, Exor N.V., iGlobe Partners and The Invus Group
Flare Therapeutics raised $123M on March 22, 2023
Investors: ShangBay Capital, Eventide Asset Management, Nextech Invest, GordonMD Global Investments LP, Third Rock Ventures and The Invus Group
Ring Therapeutics raised $87M on March 9, 2023
Investors: CJ Investment Inc., T. Rowe Price, UPMC Enterprises, Partners Investment, Flagship Ventures and The Invus Group
Noema Pharma raised $110M on March 7, 2023
Investors: UPMC Enterprises, Polaris Partners, Sofinnova Partners, JEITO, Gilde Healthcare, Forbion and The Invus Group